| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656467 | HPB | 2017 | 6 Pages |
Abstract
Patients with PHC who underwent a resection for LN+ disease had better OS than patients who did not undergo resection because of locally advanced disease at exploratory laparotomy. LN+ PHC does not preclude 5-year survival after resection.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Stefan Buettner, Jeroen L.A. van Vugt, Marcia P. Gaspersz, Robert J.S. Coelen, Eva Roos, Tim A. Labeur, Georgios A. Margonis, Cecilia G. Ethun, Shishir K. Maithel, George Poultsides, Thuy Tran, Kamran Idrees, Chelsea A. Isom, Ryan C. Fields,